Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

697
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
697
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

879
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
879
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

231
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
231
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

31.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
31.7K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

1.1K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026
Same author

Disaccharidase testing and clinical outcomes: a retrospective study.

Proceedings (Baylor University. Medical Center)·2026
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: Shared Mechanisms and Therapeutic Opportunities.

Cardiology in review·2026
Same author

Statins in Gastroenterology: Mechanisms, Human Evidence, and Safety.

Cardiology in review·2026
Same author

Co-occurrence of Gastric Xanthoma and Numerous Large Hyperplastic Polyps as a Complication of Argon Plasma Coagulation in GAVE.

ACG case reports journal·2025
Same author

Lean MASLD and Cardiovascular Disease: A Review.

Cardiology in review·2025

Related Experiment Video

Updated: Sep 16, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Hypercholesterolemia of Cholestasis.

Maxwell Charlat1, Elona Poltiyelova1, Jesse Silverman1

  • 1From the Department of Internal Medicine.

Cardiology in Review
|July 11, 2025
PubMed
Summary

Primary biliary cholangitis (PBC) causes high cholesterol but not increased cardiovascular risk. Measuring apolipoprotein B helps manage PBC hypercholesterolemia with statins or PCSK9 inhibitors.

Keywords:
atherosclerotic cardiovascular diseasecholestatic liver diseasehypercholesterolemialipoprotein Xprimary biliary cholangitis

More Related Videos

Creation of Reversible Cholestatic Rat Model
09:39

Creation of Reversible Cholestatic Rat Model

Published on: May 21, 2011

15.1K
Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.1K

Related Experiment Videos

Last Updated: Sep 16, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K
Creation of Reversible Cholestatic Rat Model
09:39

Creation of Reversible Cholestatic Rat Model

Published on: May 21, 2011

15.1K
Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.1K

Area of Science:

  • Biochemistry
  • Hepatology
  • Cardiology

Background:

  • Cholesterol homeostasis is vital, regulated by low-density lipoprotein (LDL) transport.
  • Elevated LDL cholesterol is linked to atherosclerotic cardiovascular disease.
  • Cholestatic liver diseases, like primary biliary cholangitis (PBC), disrupt cholesterol balance.

Purpose of the Study:

  • To investigate hypercholesterolemia in PBC.
  • To clarify cardiovascular risk in PBC patients.
  • To identify optimal methods for managing PBC-related hypercholesterolemia.

Main Methods:

  • Analysis of cholesterol metabolism in PBC.
  • Evaluation of cardiovascular risk factors in PBC.
  • Assessment of diagnostic biomarkers like Lipoprotein X and apolipoprotein B.
  • Review of therapeutic strategies including statins and PCSK9 inhibitors.

Main Results:

  • PBC involves impaired hepatocyte cholesterol clearance, reduced bile synthesis, and increased cholesterol production.
  • Lipoprotein X is a specific cholestasis biomarker, sometimes causing extreme hypercholesterolemia.
  • PBC hypercholesterolemia correlates with poorer liver outcomes but not higher atherosclerotic cardiovascular disease risk.
  • Apolipoprotein B measurement is the most accurate method for cardiovascular risk stratification in PBC.

Conclusions:

  • Patients with PBC experience hypercholesterolemia due to liver dysfunction, not direct cardiovascular risk.
  • Apolipoprotein B is the key biomarker for assessing cardiovascular risk in PBC.
  • Statins and PCSK9 inhibitors are effective treatments for hypercholesterolemia in cholestatic liver disease.
  • Regular monitoring of apolipoprotein B levels is essential to gauge treatment efficacy.